Edoxaban administration following enoxaparin: A pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjectsZAHIR, Hamim; MATSUSHIMA, Nobuko; HALIM, Abdel-Baset et al.Thrombosis and haemostasis. 2012, Vol 108, Num 1, pp 166-175, issn 0340-6245, 10 p.Article

Characterisation of exposure versus response of edoxaban in patients undergoing total hip replacement surgeryROHATAGI, Shashank; MENDELL, Jeanne; KASTRISSIOS, Helen et al.Thrombosis and haemostasis. 2012, Vol 108, Num 5, pp 893-901, issn 0340-6245, 9 p.Article

Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinuxWOLZT, Michael; SAMAMA, Meyer M; KAPIOTIS, Stylianos et al.Thrombosis and haemostasis. 2011, Vol 105, Num 6, pp 1080-1090, issn 0340-6245, 11 p.Article

The Effects of the Antiplatelet Agents, Aspirin and Naproxen, on Pharmacokinetics and Pharmacodynamics of the Anticoagulant Edoxaban, a Direct Factor Xa InhibitorMENDELL, Jeanne; LEE, Frank; SHUQUAN CHEN et al.Journal of cardiovascular pharmacology. 2013, Vol 62, Num 2, pp 212-221, issn 0160-2446, 10 p.Article

The P-Glycoprotein Transport System and Cardiovascular DrugsWESSLER, Jeffrey D; GRIP, Laura T; MENDELL, Jeanne et al.Journal of the American College of Cardiology. 2013, Vol 61, Num 25, pp 2495-2502, issn 0735-1097, 8 p.Article

Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillationSALAZAR, Daniel E; MENDELL, Jeanne; KUNITADA, Satoshi et al.Thrombosis and haemostasis. 2012, Vol 107, Num 5, pp 925-936, issn 0340-6245, 12 p.Article

Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillationWEITZ, Jeffrey I; CONNOLLY, Stuart J; PATEL, Indravadan et al.Thrombosis and haemostasis. 2010, Vol 104, Num 3, pp 633-641, issn 0340-6245, 9 p.Article